<DOC>
	<DOCNO>NCT00362609</DOCNO>
	<brief_summary>The purpose study determine whether consistent drug level achieve infant presumed Gastroesophageal Reflux Disease .</brief_summary>
	<brief_title>Study Evaluating Pantoprazole Neonates Preterm Infants With GERD</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Hospitalized patient Presumed diagnosis GERD Term postterm infant within neonatal period le 28 day preterm infant correct gestational age le 44 week cardiovascular instability clinically significant laboratory abnormality use warfarin , carbamazepine , phenytoin , rifampin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Safety</keyword>
</DOC>